IL148654A0 - Parathyroid hormone analogues for the treatment of osteoporosis - Google Patents

Parathyroid hormone analogues for the treatment of osteoporosis

Info

Publication number
IL148654A0
IL148654A0 IL14865400A IL14865400A IL148654A0 IL 148654 A0 IL148654 A0 IL 148654A0 IL 14865400 A IL14865400 A IL 14865400A IL 14865400 A IL14865400 A IL 14865400A IL 148654 A0 IL148654 A0 IL 148654A0
Authority
IL
Israel
Prior art keywords
osteoporosis
treatment
parathyroid hormone
hormone analogues
analogues
Prior art date
Application number
IL14865400A
Other languages
English (en)
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of IL148654A0 publication Critical patent/IL148654A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14865400A 1999-09-22 2000-09-21 Parathyroid hormone analogues for the treatment of osteoporosis IL148654A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/406,813 US6316410B1 (en) 1999-09-22 1999-09-22 Parathyroid hormone analogues for the treatment of osteoporosis
PCT/CA2000/001083 WO2001021643A2 (fr) 1999-09-22 2000-09-21 Analogues de l'hormone parathyroidienne pour le traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
IL148654A0 true IL148654A0 (en) 2002-09-12

Family

ID=23609550

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14865400A IL148654A0 (en) 1999-09-22 2000-09-21 Parathyroid hormone analogues for the treatment of osteoporosis

Country Status (13)

Country Link
US (1) US6316410B1 (fr)
EP (2) EP1214348A2 (fr)
JP (1) JP4620309B2 (fr)
CN (1) CN1377371A (fr)
AU (1) AU7398000A (fr)
BR (1) BR0016306A (fr)
CA (1) CA2384341A1 (fr)
CZ (1) CZ20021026A3 (fr)
IL (1) IL148654A0 (fr)
MX (1) MXPA02002977A (fr)
SK (1) SK4042002A3 (fr)
WO (1) WO2001021643A2 (fr)
ZA (1) ZA200202162B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ553800A0 (en) * 2000-02-10 2000-03-02 Cole, Martin Terence Improvements relating to smoke detectors particularily duct monitored smoke detectors
US20040023882A1 (en) * 2002-05-16 2004-02-05 Peri Krishna G. PTH derivatives resistant to skin proteases
US7799757B2 (en) * 2002-06-13 2010-09-21 Michael Chorev Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
JP4750416B2 (ja) * 2002-07-25 2011-08-17 ザ ジェネラル ホスピタル コーポレイション 副甲状腺ホルモン受容体の活性化と造血前駆細胞の増殖
US7635477B2 (en) * 2002-07-25 2009-12-22 The General Hospital Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
AU2002951372A0 (en) * 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
WO2005007184A2 (fr) * 2003-07-15 2005-01-27 National Research Council Of Canada Analogues cycliques de l'hormone parathyroide humaine destines au traitement d'etats caracterises par l'hyperproliferation des cellules de la peau
EP1557176A1 (fr) * 2004-01-26 2005-07-27 Ferring B.V. Utilisation d' agonistes du récepteur de PTH pour le traitement des métastases de l'os
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US9114069B2 (en) * 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US8642564B2 (en) * 2004-08-25 2014-02-04 Aegis Therapeutics, Llc Compositions for drug administration
US20060046969A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Antibacterial compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
JP2009508820A (ja) * 2005-09-06 2009-03-05 ゼロス セラピューティクス， インコーポレイテッド 副甲状腺ホルモンアナログおよび使用法
US20110046059A1 (en) * 2005-09-06 2011-02-24 Zelos Therapeutics, Inc. Pharmaceutically acceptable formulations/compositions for peptidyl drugs
WO2007059470A2 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
US20090022684A1 (en) * 2006-05-09 2009-01-22 Paul Morley Methods for hematopoietic stimulation
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
JP2010501476A (ja) * 2006-07-31 2010-01-21 ゼロス セラピューティクス， インコーポレイテッド 副甲状腺ホルモン類似体およびその使用方法
WO2008048784A1 (fr) * 2006-10-13 2008-04-24 Eli Lilly And Company PHT pégylés en tant que modulateurs du récepteur PHT et leurs utilisations
EP1961765A1 (fr) * 2006-12-08 2008-08-27 Zealand Pharma A/S Peptides PTH tronqués à formation cyclique
AU2009228093B2 (en) 2008-03-28 2014-08-07 Neurelis, Inc. Administration of benzodiazepine compositions
US8440631B2 (en) * 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US8563513B2 (en) 2009-03-27 2013-10-22 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
ES2683902T3 (es) 2011-06-14 2018-09-28 Hale Biopharma Ventures, Llc Administración de benzodiacepina
IL310069A (en) 2015-04-29 2024-03-01 Radius Pharmaceuticals Inc Cancer treatment methods
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
WO2018129419A1 (fr) 2017-01-05 2018-07-12 Radius Pharmaceuticals, Inc. Formes polymorphes de rad1901-2hcl
SG11202013177WA (en) 2018-07-04 2021-01-28 Radius Pharmaceuticals Inc Polymorphic forms of rad 1901-2hcl

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556940A (en) * 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
US6110892A (en) * 1994-06-20 2000-08-29 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
DE19508672A1 (de) 1995-03-10 1996-09-12 Boehringer Mannheim Gmbh Neue cyclische Parathormonfragmente, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
GEP20033095B (en) 1996-08-02 2003-10-27 Nat Res Council Canada Parathyroid Hormone Analogues for the Treatment of Osteoporosis
BR9808786A (pt) 1997-05-14 2000-07-11 Rhone Poulenc Rorer Pharma Composto peptìdio cìclico ou um seu sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, processos para tratar doenças associadas com a regulagem do cálcio em um paciente e para tratar a osteopenia ou a osteoporose em um mamìfero hospedeiro

Also Published As

Publication number Publication date
AU7398000A (en) 2001-04-24
JP4620309B2 (ja) 2011-01-26
EP1214348A2 (fr) 2002-06-19
BR0016306A (pt) 2003-04-08
CZ20021026A3 (cs) 2003-05-14
EP1881006A1 (fr) 2008-01-23
WO2001021643A2 (fr) 2001-03-29
MXPA02002977A (es) 2004-09-06
CA2384341A1 (fr) 2001-03-29
US6316410B1 (en) 2001-11-13
WO2001021643A3 (fr) 2001-10-25
ZA200202162B (en) 2003-08-27
JP2003510256A (ja) 2003-03-18
SK4042002A3 (en) 2002-12-03
CN1377371A (zh) 2002-10-30

Similar Documents

Publication Publication Date Title
IL148654A0 (en) Parathyroid hormone analogues for the treatment of osteoporosis
LT99010A (en) Parathyroid hormone analogues for the treatment of osteoporosis
PL339449A1 (en) Treatment of bone fractures involving the use of pthrp analogues
ZA988886B (en) Formulation for treatment of osteoporosis
HUP9900604A3 (en) New peptide compounds that are analogues of the glucagon-like p
HUP9904596A3 (en) Analogs of parathyroid hormone
AU5003401A (en) Hormone replacement therapy
AU6152200A (en) Azolylbenzamides and analogues and their use for treating osteoporosis
IL132901A0 (en) Peptide parathyroid hormone analogs
IL187030A0 (en) Use of retigabine for the treatment of neuropathic pain
SI1506041T1 (sl) Ibandronska kislina za zdravljenje in preprecevanje osteoporoze
ZA200308027B (en) Hormone replacement therapy
IL159000A0 (en) Quinazoline derivatives which promote the release of parathyroid hormone
EP0779812A4 (fr) Procedes de traitement de l'osteoporose utilisant des phosphonates osteoactifs et une hormone parathiro dienne
AU2003239869A8 (en) Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
IL147862A0 (en) Process and intermediates for the preparation os isoxazolecaroxamides and analogues
EP0981545A4 (fr) Traitement de l'osteoporose
ZA200304047B (en) Analogues of GLP-1.
HUP0203741A3 (en) Treatment of osteoporosis
IL120955A0 (en) Treatment of osteoporosis
EP1207895A4 (fr) Peptide et analogues peptidiques destines au traitement et a la prevention du diabete
HU0600009D0 (en) Analogs of parathyroid hormone
SI1175904T1 (sl) Alendronat za rabo pri zdravljenju osteoporoze
ZA961859B (en) Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
SI1021194T1 (en) New improved formulation for treatment of osteoporosis